Leta i den här bloggen

torsdag 4 juni 2015

1996 Free Paper Abstracts. A98- A125 Serology.

A98.  Screening relatives of patients with coeliac disedase by means of serum anti-endomysium antibodies .

A99  Human umbilical vein endthelial cells: a new easily available substrate for detecting endomysial antibodies in patients with coeliac disease (Dublin)

A100. Antiednomysium antibody on human umbilical cord vein: a cheap and sensitive diagnostic tool for the screening of celiac disease (Trieste, Italy)

A101.  Evaluation of the endomysiual antibody test in screening for coeliac disease: in a clinical practice setting.  (Dublin)

A102. Human umbilical cord tissue: a suitable substrate for endomysial antibody detection. (UK)

A103. Endomysium autoantibodies on human umbilical cord (HUC) in coeliac disease (Finland)

A104.  Human umbilical cord-derived fibroblasts as antigen in whole cell Elisa for coeliac disease antibodies (Finland)

A105. Connective tissue substrates in serum screening for coeliac disedase (CD).(Tübingen, Germany)

A106. Same substrate for antiendomysium, anti-jejunum and anti-reticulin assay. (Budapest,Hungary)

A107. Endomysium antibodies (EmA) and detection of silent coeliac disease (Barcelona, Spain)

A108.  Human umbilical cord antibodies (HUC-Ab) for CD-screening (Barcelona, spain)

A109 Endomysial antibodies in relation n to celiac disease (CB) activity in lamina propria of jejunal mucosa. (Prague)

A110. Frequency of aspecific staining in the anti-endomysium antibody assay (Budapest, Hungary)

A111.  Improving methods in serum screening for coeliac disease (Tübingen,Germany)

A112. Human liver- suitable antigen for reticulin antibody determination, a prospective study. (Czech Republic)

A113. Three immunological markers may replace intestinal biopsy in the diagnostic approach of coeliac disease (AGA, EMA, ARA)  (Thessaloniki, Greece)

A114. Chronic liver disease may be a cause of false positive anti-endomysium antibody assay. (Scotland, UK)

A115. Screening for coeliac disease with Pharmacia CAP system for detectin anti-gliadin IgG and IgA. (Uppsala, Sweden)

A116.  Dietary intake and false positivity of coeliac disease associated antibodies.(Belfast,  N-Ireland)

A117. UniCAP Gliadin IgA and IgG. New in vitro test system for diagnosis and monitoring of coeliac disease (Uppsala, Sweden)

A118.  The differential diagnosis of coeiac disease and other malabsorption syndromes: IgAEmA and IgGEmA tests (Warsaw, Poland)

A119. Screening tests for coeliac disease using antiendomysium antibody on human umbilical cord section (Budapest, Hungary)

A120. Serological methods for antigliadin antibody (AGA) testing: Secalins as an alternative to gliadins. (Madrid, Spain)

A121. Evaluation of the first quantitative method for the measurement of serum anti-gliadin antibodies (AGA)(Valencia, Spain)

A122. Lack of IgG-type serum anti-endomysium and anti-jejunum antibodies in dermatitis herpetiformis patients. (Budapest, Hungary)

A123. Anti-gliadin antibody producing cells in blood of children with coeliac  disease. (Uppsala, Sweden)

A124. Human  umbilical cord tissue (HUCT) : Substrate for the detection of endomysial antibodies (Dublin, Ireland)

A125.  Screening for coeliac disease among 15- and 16- years old adolescents with gliadin- and endomysial antibodies (Göteborg, Sweden) 

Inga kommentarer: